Those who have failed oral medications often respond well to the injectable format
Idnurm et al
In the quest to bring new generations of weight-loss and diabetes drugs to market, Novo Nordisk, Lilly, and several other companies, big and small, have set their sights on targets other than GLP-1
5 A serious adverse event is one that has at least one of the following outcomes: Results in death, is life threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent disability/incapacity, is a congenital anomaly/birth defect, or involves an important medical event
Khan, Ryan Ziemiecki, and J
Heres a closer look at T1D complications